Aripiprazole-associated Neuroleptic Malignant Syndrome in an Antipsychotic-naïve Patient

Aripiprazole用於初發精神病病人相關之抗精神病藥物惡性症候群

鄧博仁(Po-Ren Teng)；黃桂耀(Kuei-Yao Haung)

台灣精神醫學

30卷1期（2016 / 03 / 01）

75 - 77

英文

1. Carroll, BT(2000).The universal field hypothesis of catatonia and neuroleptic malignant syndrome.CNS Spectr,7,26-33.
2. Duggal, HS,Kithas, J(2005).Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine.Am J Psychiatry,162,397-398.
3. Gründer, G,Carlsson, A,Wong, DF(2003).Mechanism of new antipsychotic medications.Arch Gen Psychiatry,60,974-977.
4. Gründer, G,Fellows, C,Janouschek, H(2008).Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.Am J Psychiatry,165,988-995.
5. Keck, PE, Jr.,Marcus, R,Tourkodimitris, S(2003).A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.Am J Psychiatry,160,1651-1658.
6. Kinon, BJ,Stauffer, VL,Kollack-Walker, S,Chen, L,Sniadecki, J(2008).Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.J Clin Psychopharmacol,28,601-607.
7. Pelonero, AL,Levenson, JL,Pandurangi, AK(1998).Neuroleptic malignant syndrome: a review.Psychiatr Serv,49,1163-1172.
8. Srephichit, S,Sanchez, R,Bourgeois, JA(2006).Neuroleptic malignant syndrome and aripiprazole in an antipsychotic-naïve patient.J Clin Psychopharmacol,26,94-95.
9. Suzuki, A,Kondo, T,Otani, K(2001).Association of the TaqI A polymorphism of the dopamine D2 receptor gene with predisposition to neuroleptic malignant syndrome.Am J Psychiatry,158,1714-1716.
10. Trollor, JN,Chen, X,Sachdev, PS(2009).Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.CNS Drugs,23,477-492.
11. Young, C(1997).A case of neuroleptic malignant syndrome and serotonin disturbance.J Clin Psychopharmacol,17,65-66.